CN116678810A - Cell Proliferation Immunofluorescence Detection Kit and Its Application - Google Patents
Cell Proliferation Immunofluorescence Detection Kit and Its Application Download PDFInfo
- Publication number
- CN116678810A CN116678810A CN202210167020.2A CN202210167020A CN116678810A CN 116678810 A CN116678810 A CN 116678810A CN 202210167020 A CN202210167020 A CN 202210167020A CN 116678810 A CN116678810 A CN 116678810A
- Authority
- CN
- China
- Prior art keywords
- cells
- cell
- cell proliferation
- washing
- antibody
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 230000004663 cell proliferation Effects 0.000 title claims abstract description 27
- 238000001514 detection method Methods 0.000 title claims abstract description 19
- 238000010166 immunofluorescence Methods 0.000 title claims abstract description 11
- 210000004027 cell Anatomy 0.000 claims abstract description 96
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 21
- 108010033040 Histones Proteins 0.000 claims abstract description 17
- 102000006947 Histones Human genes 0.000 claims abstract description 17
- 102000039446 nucleic acids Human genes 0.000 claims abstract description 15
- 108020004707 nucleic acids Proteins 0.000 claims abstract description 15
- 150000007523 nucleic acids Chemical class 0.000 claims abstract description 15
- 239000003550 marker Substances 0.000 claims abstract description 11
- 239000000243 solution Substances 0.000 claims description 24
- 238000005406 washing Methods 0.000 claims description 20
- 238000000034 method Methods 0.000 claims description 16
- 229930040373 Paraformaldehyde Natural products 0.000 claims description 10
- 239000012528 membrane Substances 0.000 claims description 10
- 229920002866 paraformaldehyde Polymers 0.000 claims description 10
- FWBHETKCLVMNFS-UHFFFAOYSA-N 4',6-Diamino-2-phenylindol Chemical compound C1=CC(C(=N)N)=CC=C1C1=CC2=CC=C(C(N)=N)C=C2N1 FWBHETKCLVMNFS-UHFFFAOYSA-N 0.000 claims description 9
- 238000010186 staining Methods 0.000 claims description 9
- 239000000834 fixative Substances 0.000 claims description 7
- GPRLSGONYQIRFK-MNYXATJNSA-N triton Chemical compound [3H+] GPRLSGONYQIRFK-MNYXATJNSA-N 0.000 claims description 7
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 6
- 201000010099 disease Diseases 0.000 claims description 6
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims description 6
- 210000001082 somatic cell Anatomy 0.000 claims description 6
- 239000007850 fluorescent dye Substances 0.000 claims description 5
- 239000011521 glass Substances 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 4
- 239000007983 Tris buffer Substances 0.000 claims description 3
- 229960005070 ascorbic acid Drugs 0.000 claims description 3
- 235000010323 ascorbic acid Nutrition 0.000 claims description 3
- 239000011668 ascorbic acid Substances 0.000 claims description 3
- 239000006285 cell suspension Substances 0.000 claims description 3
- 238000003745 diagnosis Methods 0.000 claims description 3
- 239000000523 sample Substances 0.000 claims description 3
- 239000012723 sample buffer Substances 0.000 claims description 3
- 239000002904 solvent Substances 0.000 claims description 3
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 claims description 3
- 241000288906 Primates Species 0.000 claims description 2
- 238000002360 preparation method Methods 0.000 claims description 2
- 230000001105 regulatory effect Effects 0.000 claims description 2
- 238000003149 assay kit Methods 0.000 claims 1
- 239000006059 cover glass Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 230000001225 therapeutic effect Effects 0.000 claims 1
- 230000022131 cell cycle Effects 0.000 abstract description 12
- 238000002474 experimental method Methods 0.000 abstract description 6
- 230000010337 G2 phase Effects 0.000 abstract description 5
- 210000004895 subcellular structure Anatomy 0.000 abstract description 5
- 238000004163 cytometry Methods 0.000 abstract description 2
- 238000003234 fluorescent labeling method Methods 0.000 abstract description 2
- 230000035945 sensitivity Effects 0.000 abstract description 2
- 230000027311 M phase Effects 0.000 description 15
- 239000003795 chemical substances by application Substances 0.000 description 9
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 238000000684 flow cytometry Methods 0.000 description 6
- 230000008569 process Effects 0.000 description 6
- 230000018199 S phase Effects 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 238000001917 fluorescence detection Methods 0.000 description 4
- 238000012803 optimization experiment Methods 0.000 description 4
- 230000035755 proliferation Effects 0.000 description 4
- 108090000623 proteins and genes Proteins 0.000 description 4
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 4
- 229930182490 saponin Natural products 0.000 description 4
- 150000007949 saponins Chemical class 0.000 description 4
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000010413 mother solution Substances 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 230000004668 G2/M phase Effects 0.000 description 2
- 230000001464 adherent effect Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000006143 cell culture medium Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical compound CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 2
- 239000012224 working solution Substances 0.000 description 2
- CDEURGJCGCHYFH-CFCGPWAMSA-N 5-ethynyl-1-[(2r,5r)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione Chemical compound C1C(O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(C#C)=C1 CDEURGJCGCHYFH-CFCGPWAMSA-N 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 208000026350 Inborn Genetic disease Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 208000037273 Pathologic Processes Diseases 0.000 description 1
- 239000012980 RPMI-1640 medium Substances 0.000 description 1
- 238000012300 Sequence Analysis Methods 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 238000007877 drug screening Methods 0.000 description 1
- 238000004043 dyeing Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 208000016361 genetic disease Diseases 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 230000009054 pathological process Effects 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229940113082 thymine Drugs 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N15/14—Optical investigation techniques, e.g. flow cytometry
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/2813—Producing thin layers of samples on a substrate, e.g. smearing, spinning-on
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N1/00—Sampling; Preparing specimens for investigation
- G01N1/28—Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
- G01N1/30—Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5091—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/5302—Apparatus specially adapted for immunological test procedures
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N15/00—Investigating characteristics of particles; Investigating permeability, pore-volume or surface-area of porous materials
- G01N15/10—Investigating individual particles
- G01N2015/1006—Investigating individual particles for cytology
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- Physiology (AREA)
- Dispersion Chemistry (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
本发明提供一种细胞增殖免疫荧光检测试剂盒及其应用。本发明在现有核酸荧光标记方法的基础上,通过引入M期细胞特殊标记(磷酸化组蛋白H3)以有效区分G2和M期细胞。通过甄选优化实验基础条件,使基础核酸标记物,新合成核酸标记物,以及M期细胞特殊标记能够兼容,从而完成对四个细胞周期的全面检测。进一步结合免疫荧光细胞术定性或定量观测不同细胞增殖周期细胞的亚细胞结构,从而能够准确反映出细胞增殖周期的全部信息。本发明提供的细胞周期检测方法具有操作简单、高效、敏感,试剂廉价易得等优点,可以对细胞样本进行定性,定量和定位检测,应用前景广阔。The invention provides a cell proliferation immunofluorescence detection kit and application thereof. Based on the existing nucleic acid fluorescent labeling method, the present invention effectively distinguishes G2 and M phase cells by introducing a special marker for M phase cells (phosphorylated histone H3). By selecting and optimizing the basic conditions of the experiment, the basic nucleic acid markers, newly synthesized nucleic acid markers, and special markers of M phase cells are compatible, so as to complete the comprehensive detection of the four cell cycles. Further combined with immunofluorescence cytometry to qualitatively or quantitatively observe the subcellular structure of cells in different cell proliferation cycles, so as to accurately reflect all the information of the cell proliferation cycle. The cell cycle detection method provided by the invention has the advantages of simple operation, high efficiency, sensitivity, cheap and easy-to-obtain reagents, etc., can perform qualitative, quantitative and location detection on cell samples, and has broad application prospects.
Description
技术领域technical field
本发明涉及生物技术领域,具体地说,涉及一种细胞增殖免疫荧光检测试剂盒及其应用。The invention relates to the field of biotechnology, in particular to a cell proliferation immunofluorescence detection kit and its application.
背景技术Background technique
细胞增殖是维持生命的基础,是一个非常复杂精密调控的生理过程。根据增殖过程中的核酸,蛋白质及细胞整体变化特征,细胞的增殖周期可以人为分成G1,S,G2和M四个周期。Cell proliferation is the basis for maintaining life and is a very complex and finely regulated physiological process. According to the characteristics of nucleic acid, protein and overall cell changes during the proliferation process, the cell proliferation cycle can be artificially divided into four cycles: G1, S, G2 and M.
很多遗传病,感染性疾病以及肿瘤等疾病发生发展都和细胞的增殖周期异常直接相关,因此细胞增殖周期的检测是判断细胞病理机制的重要手段,也是临床和基础生物医学科研中常用的实验方法。The occurrence and development of many genetic diseases, infectious diseases, tumors and other diseases are directly related to abnormal cell proliferation cycle. Therefore, the detection of cell proliferation cycle is an important means to judge the pathological mechanism of cells, and it is also a commonly used experimental method in clinical and basic biomedical research. .
免疫荧光术结合荧光显微镜及自动数据处理系统,可以定性或定量观测不同周期细胞的数量、比例、亚细胞结构及相关蛋白的表达分布等,是生物医学领域最常用的技术手段之一。Immunofluorescence combined with fluorescence microscope and automatic data processing system can qualitatively or quantitatively observe the number, proportion, subcellular structure and expression distribution of related proteins in different cycle cells, and is one of the most commonly used technical means in the field of biomedicine.
目前国内外细胞增殖周期的检测方法主要有两类,第一类是直接用核酸试剂(如PI,DAPI,HOECHST等)染细胞DNA,通过观测不同细胞周期细胞DNA荧光含量不同而对细胞周期进行分析。此方法非常简单,易操作;但是实验结果分析很困难,容易产生诸多误差,尤其是对S和M期细胞的分析很不可靠。目前只适合于结合流式细胞术做一些药物初筛。At present, there are mainly two types of detection methods for the cell proliferation cycle at home and abroad. The first type is to directly use nucleic acid reagents (such as PI, DAPI, HOECHST, etc.) analyze. This method is very simple and easy to operate; however, the analysis of experimental results is very difficult and prone to many errors, especially the analysis of cells in S and M phases is very unreliable. At present, it is only suitable for some drug screening combined with flow cytometry.
第二类是在第一类核酸试剂的基础上,另外用核苷酸类似物(如EdU)标记新合成的DNA,以用于区分S期细胞。由于S期细胞可以被标记信号放大显示,所以此方法可以将细胞分成G1,S和G2M三个周期。此方法可以用于研究一些影响G1/S,S/G2周期的病理过程,但是对G2/M周期却没有办法检测。不仅无法提供细胞增殖周期全部信息,而且对G2/M周期过渡有影响的疾病完全不能检验。因此,亟需建立一种用于有效区分鉴别M和G2期细胞结构的方法。The second type is based on the first type of nucleic acid reagents, and additionally uses nucleotide analogs (such as EdU) to label newly synthesized DNA for distinguishing S phase cells. Since cells in S phase can be amplified and displayed by marker signals, this method can divide cells into three cycles of G1, S and G2M. This method can be used to study some pathological processes that affect the G1/S, S/G2 cycle, but there is no way to detect the G2/M cycle. Not only can it not provide all the information on the cell proliferation cycle, but also the diseases that affect the G2/M cycle transition cannot be tested at all. Therefore, there is an urgent need to establish a method for effectively distinguishing and identifying cell structures in M and G2 phases.
发明内容Contents of the invention
本发明的目的是提供一种细胞增殖免疫荧光检测试剂盒及其应用。The purpose of the present invention is to provide a cell proliferation immunofluorescence detection kit and its application.
为了实现本发明目的,第一方面,本发明提供磷酸化组蛋白H3作为细胞增殖周期中M期标志物中的应用。In order to achieve the purpose of the present invention, in a first aspect, the present invention provides the use of phosphorylated histone H3 as a marker of M phase in the cell proliferation cycle.
第二方面,本发明提供检测磷酸化组蛋白H3的试剂在制备用于区分细胞增殖周期中M期的检测试剂中的应用。In a second aspect, the present invention provides an application of a reagent for detecting phosphorylated histone H3 in the preparation of a detection reagent for distinguishing the M phase of the cell proliferation cycle.
前述的应用,所述检测磷酸化组蛋白H3的试剂为抗磷酸化组蛋白H3抗体,如抗人p-H3-Alexa Fluro647抗体(Abcam,ab237418)。For the aforementioned application, the reagent for detecting phosphorylated histone H3 is an anti-phosphorylated histone H3 antibody, such as an anti-human p-H3-Alexa Fluro647 antibody (Abcam, ab237418).
第三方面,本发明提供一种细胞增殖免疫荧光检测试剂盒(细胞周期荧光检测试剂盒),所述试剂盒包含磷酸化组蛋白H3抗体。In a third aspect, the present invention provides a cell proliferation immunofluorescence detection kit (cell cycle fluorescence detection kit), the kit comprising phosphorylated histone H3 antibody.
进一步地,所述试剂盒还包含新合成DNA标记物、细胞固定剂、破膜剂和总核酸荧光染色剂等中的至少一种。Further, the kit also includes at least one of a newly synthesized DNA marker, a cell fixative, a membrane breaking agent, and a fluorescent staining agent for total nucleic acid.
所述新合成DNA标记物可以是Edu(5-乙炔基-2-脱氧尿苷,为胸腺嘧啶替代物)。The newly synthesized DNA marker may be Edu (5-ethynyl-2-deoxyuridine, a substitute for thymine).
所述细胞固定剂可以是1-4%(优选2%)多聚甲醛。其配置方法如下:将粉剂多聚甲醛溶于双蒸水中,以配制质量比40%母液。加热搅拌并滴加NaOH至粉剂完全溶解,-20℃冻存母液。使用时取母液溶解,用PBS稀释母液至1-4v/v%工作液。The cell fixative may be 1-4% (preferably 2%) paraformaldehyde. Its configuration method is as follows: dissolving powder paraformaldehyde in double distilled water to prepare mother liquor with a mass ratio of 40%. Heat and stir and add NaOH dropwise until the powder is completely dissolved, and freeze the mother solution at -20°C. When using, take the mother solution and dissolve it, and dilute the mother solution to 1-4v/v% working solution with PBS.
所述破膜剂可以是含0.1-1%(优选0.1%)Triton的PBS。The membrane breaking agent may be PBS containing 0.1-1% (preferably 0.1%) Triton.
所述荧光染色剂可以是DAPI。The fluorescent stain can be DAPI.
第四方面,本发明提供所述试剂盒在检测细胞增殖周期M期中的应用(含非疾病诊断和治疗目的)。In the fourth aspect, the present invention provides the application of the kit in detecting the M phase of the cell proliferation cycle (including non-disease diagnosis and treatment purposes).
第五方面,本发明提供一种检测细胞增殖周期M期的方法(含非疾病诊断和治疗目的),包括以下步骤:In a fifth aspect, the present invention provides a method for detecting the M phase of the cell proliferation cycle (including non-disease diagnosis and treatment purposes), comprising the following steps:
(1)将细胞置于含1-10μM Edu的细胞完全培养基中培养0.5-4小时;(1) Cells are placed in a complete cell culture medium containing 1-10 μM Edu for 0.5-4 hours;
(2)培养结束后,将细胞用PBS洗涤2-3次后,用2%多聚甲醛室温下固定细胞20分钟后,用洗涤液(含10%FCS的PBS)清洗细胞(去除固定液);(2) After the culture is over, wash the cells with PBS 2-3 times, fix the cells with 2% paraformaldehyde at room temperature for 20 minutes, wash the cells with washing solution (PBS containing 10% FCS) (remove the fixing solution) ;
(3)用破膜剂(含0.1v/v%Triton的PBS)室温下处理细胞20分钟后,用洗涤液清洗细胞(去除破膜剂);(3) After treating the cells with a membrane-breaking agent (PBS containing 0.1v/v% Triton) at room temperature for 20 minutes, wash the cells with a washing solution (remove the membrane-breaking agent);
(4)用Edu标记溶剂(含有1mM CuSO4、0.1μM azide-Alexa Fluro 488和100mM抗坏血酸的100mM Tris溶液)重悬细胞,室温下处理细胞20分钟后,用洗涤液清洗细胞(去除多余试剂);(4) Resuspend the cells with Edu labeling solvent (100mM Tris solution containing 1mM CuSO 4 , 0.1μM azide-Alexa Fluro 488 and 100mM ascorbic acid), treat the cells at room temperature for 20 minutes, and wash the cells with washing solution (to remove excess reagents) ;
(5)加入10μg/ml p-H3-Alexa Fluro647重悬细胞,4℃染色细胞30分钟后,用洗涤液清洗细胞(去除多余抗体);(5) Add 10 μg/ml p-H3-Alexa Fluro647 to resuspend the cells, stain the cells at 4°C for 30 minutes, and wash the cells with washing solution (to remove excess antibodies);
(6)用PBS将细胞调整到合适浓度,将细胞悬液甩片到载玻片上;(6) Adjust the cells to an appropriate concentration with PBS, and spin the cell suspension onto a glass slide;
(7)用1μg/ml DAPI室温下染色10分钟后,用PBS洗涤4-5次;(7) After staining with 1 μg/ml DAPI at room temperature for 10 minutes, wash with PBS 4-5 times;
(8)滴加上样缓冲液(90v/v%甘油+10v/v%pH9的PBS),加上盖玻片,并封片;(8) Add sample buffer solution (90v/v% glycerol+10v/v%pH9 PBS) dropwise, add a cover slip, and mount the slide;
(9)将细胞样本在荧光显微镜下观察。(9) Observing the cell sample under a fluorescence microscope.
如果实验对象为贴壁细胞,则需要将步骤(6)去除,并在步骤(2)中将细胞直接培养到载玻片上。If the experimental object is adherent cells, step (6) needs to be removed, and the cells are directly cultured on the glass slide in step (2).
所述细胞为哺乳动物体细胞,优选灵长类动物体细胞,更优选人类体细胞。The cells are mammalian somatic cells, preferably primate somatic cells, more preferably human somatic cells.
借由上述技术方案,本发明至少具有下列优点及有益效果:By virtue of the above technical solutions, the present invention has at least the following advantages and beneficial effects:
为了突破传统细胞增殖周期检测技术的局限,本发明提供一种新型的细胞周期荧光检测试剂盒。本发明在现有核酸荧光标记方法的基础上,通过引入M期细胞特殊标记(磷酸化组蛋白H3)以有效区分G2和M期细胞。通过甄选优化实验基础条件,使基础核酸标记物,新合成核酸标记物,以及M期细胞特殊标记能够兼容,从而完成对四个细胞周期的全面检测。进一步结合免疫荧光细胞术定性或定量观测不同细胞增殖周期细胞的亚细胞结构,从而能够准确反映出细胞增殖周期的全部信息。本发明提供的细胞周期检测方法具有操作简单、高效、敏感,试剂廉价易得等优点,可以对细胞样本进行定性,定量和定位检测,应用前景广阔。In order to break through the limitation of traditional cell proliferation cycle detection technology, the present invention provides a novel cell cycle fluorescence detection kit. Based on the existing nucleic acid fluorescent labeling method, the present invention effectively distinguishes G2 and M phase cells by introducing a special marker for M phase cells (phosphorylated histone H3). By selecting and optimizing the basic conditions of the experiment, the basic nucleic acid markers, newly synthesized nucleic acid markers, and special markers of M phase cells are compatible, so as to complete the comprehensive detection of the four cell cycles. Further combined with immunofluorescence cytometry to qualitatively or quantitatively observe the subcellular structure of cells in different cell proliferation cycles, so as to accurately reflect all the information of the cell proliferation cycle. The cell cycle detection method provided by the invention has the advantages of simple operation, high efficiency, sensitivity, cheap and easy-to-obtain reagents, etc., can perform qualitative, quantitative and location detection on cell samples, and has broad application prospects.
附图说明Description of drawings
图1为本发明较佳实施例中利用细胞周期荧光检测试剂盒对K562细胞增殖周期的检测结果。Fig. 1 is the result of detecting the proliferation cycle of K562 cells using the cell cycle fluorescence detection kit in a preferred embodiment of the present invention.
图2为本发明较佳实施例中染色后的细胞用流式细胞术检测验证结果。Fig. 2 is the flow cytometry detection verification result of stained cells in a preferred embodiment of the present invention.
图3为本发明较佳实施例中固定剂破膜剂筛选优化实验结果;其中,A:2%多聚甲醛及saponin(皂素);B:2%多聚甲醛及含0.1v/v%Triton的PBS;C:低温乙醇;D:商用试剂盒(ThermoFisher Scientific,货号A10266)。Fig. 3 is the result of the screening optimization experiment of fixative membrane breaker in the preferred embodiment of the present invention; Wherein, A: 2% paraformaldehyde and saponin (saponin); B: 2% paraformaldehyde and containing 0.1v/v% Triton's PBS; C: low temperature ethanol; D: commercial kit (ThermoFisher Scientific, Cat. No. A10266).
图4为本发明较佳实施例中p-H3-Alexa Fluro647抗体优选实验结果;其中,A:pS28-H3-Histone-APC(Miltenyi,130-126-509);B:pS28-H3-Histone-Alexa Fluro647(BD,558609);C:pS10-H3-Histone-Alexa Fluro647(Abcam,ab5176);D:pS28-H3-Histone-Alexa Fluro647(Abcam,ab237418)。Figure 4 is the preferred experimental results of the p-H3-Alexa Fluro647 antibody in a preferred embodiment of the present invention; among them, A: pS28-H3-Histone-APC (Miltenyi, 130-126-509); B: pS28-H3-Histone- Alexa Fluro647 (BD, 558609); C: pS10-H3-Histone-Alexa Fluro647 (Abcam, ab5176); D: pS28-H3-Histone-Alexa Fluro647 (Abcam, ab237418).
图5为本发明较佳实施例中不同来源Edu优选实验结果;其中,A:Invitrogen,A10266;B:Aladdin,E131265;C:RHAWN,R014330;D:MCE,HY118411。Figure 5 is the preferred experimental results of Edu from different sources in the preferred embodiment of the present invention; among them, A: Invitrogen, A10266; B: Aladdin, E131265; C: RHAWN, R014330; D: MCE, HY118411.
具体实施方式Detailed ways
本发明旨在提供M期细胞特异性标记蛋白用于区分G2和M期细胞,以全面检测四个不同细胞增殖周期细胞的亚细胞结构。另外,通过选择适合新合成DNA和基础DNA标记物,用于标记不同细胞周期的核酸;进一步地,筛选最佳细胞固定剂,破膜剂,荧光染色剂等试剂,并使它们都能和标记蛋白等兼容。The present invention aims to provide M-phase cell-specific marker protein for distinguishing G2 and M-phase cells, so as to comprehensively detect the subcellular structure of cells in four different cell proliferation cycles. In addition, by selecting suitable newly synthesized DNA and basic DNA markers, it can be used to mark nucleic acids in different cell cycles; Compatible with proteins, etc.
本发明采用如下技术方案:The present invention adopts following technical scheme:
发明人通过大量研究发现磷酸化组蛋白H3只在M期细胞中表达,而其他细胞周期均不表达,由此可以成为一个优良的M期标记物。通过蛋白序列分析,筛选到若干个候选抗体。结合流式细胞术和免疫荧光术,确定最佳抗体,并制备得到特异性荧光抗体,用于检测磷酸化组蛋白H3的表达情况。其次,选择敏感特异的Edu作为核酸类似物以标记新合成DNA,并用对应荧光标记物标记;选择DAPI标记DNA,该试剂适应性广,在多种试剂环境下都可以标记核酸。最后,在众多常用的固定剂-破膜剂-荧光染色剂组合中,成功筛选出最佳的试剂组合,能兼容本实验中所使用到的所有试剂,使得四个周期的亚细胞结构都可以在荧光显微镜下定性、定量和定位观测到。Through extensive research, the inventors have found that phosphorylated histone H3 is only expressed in M phase cells, but not expressed in other cell cycles, thus it can become an excellent M phase marker. Through protein sequence analysis, several candidate antibodies were screened. Combining flow cytometry and immunofluorescence to determine the best antibody and prepare a specific fluorescent antibody for detecting the expression of phosphorylated histone H3. Second, select sensitive and specific Edu as nucleic acid analogs to label newly synthesized DNA, and label with corresponding fluorescent markers; select DAPI to label DNA, which has wide adaptability and can label nucleic acids in a variety of reagent environments. Finally, among many commonly used combinations of fixative-membrane breaking agent-fluorescent staining agent, the best combination of reagents was successfully screened out, which is compatible with all the reagents used in this experiment, so that the four cycles of subcellular structures can be It was observed qualitatively, quantitatively and localized under a fluorescence microscope.
以下实施例用于说明本发明,但不用来限制本发明的范围。若未特别指明,实施例中所用的技术手段为本领域技术人员所熟知的常规手段,所用原料均为市售商品。The following examples are used to illustrate the present invention, but are not intended to limit the scope of the present invention. Unless otherwise specified, the technical means used in the examples are conventional means well known to those skilled in the art, and the raw materials used are all commercially available products.
本发明中涉及到的百分号“%”,若未特别说明,是指质量百分比;但溶液的百分比,除另有规定外,是指100mL溶液中含有溶质的克数。The percentage sign "%" involved in the present invention refers to the mass percentage unless otherwise specified; but the percentage of the solution refers to the grams of solute contained in 100 mL of the solution, unless otherwise specified.
以下实施例中使用的试剂及仪器:Reagents and instruments used in the following examples:
抗人p-H3-Alexa Fluro647抗体购自Abcam(货号ab237418)Anti-human p-H3-Alexa Fluro647 antibody was purchased from Abcam (Cat. No. ab237418)
azide-Alexa Fluro488购自ThermoFisher Scientific(货号A10266)。K562细胞购自ATCC(CCL-243)。Azide-Alexa Fluro488 was purchased from ThermoFisher Scientific (Cat. No. A10266). K562 cells were purchased from ATCC (CCL-243).
FCS购自Gibco(16000044)。FCS was purchased from Gibco (16000044).
流式细胞仪购自BD FACSAria(BD,643181)。Flow cytometer was purchased from BD FACSAria (BD, 643181).
激光共聚焦显微镜为Leica TCS SP5。Laser confocal microscope was Leica TCS SP5.
实施例1免疫荧光法检测细胞周期(区分M和G2期细胞)Example 1 Immunofluorescence detection of cell cycle (differentiation of M and G2 phase cells)
1、1-10μM Edu(购自Aladdin,E131265)培养K562细胞;将1-10mM Edu工作溶液按1:1000体积比加入细胞完全培养基(含10%胎牛血清的RPMI 1640培养基,购自ThermoFisher,货号11875093)中,根据细胞增殖速度培养0.5-4小时。1. K562 cells were cultured with 1-10 μM Edu (purchased from Aladdin, E131265); 1-10 mM Edu working solution was added to the complete cell culture medium (RPMI 1640 medium containing 10% fetal bovine serum, purchased from ThermoFisher, Cat. No. 11875093), cultured for 0.5-4 hours according to the cell proliferation rate.
2、收获细胞;低温PBS洗涤2-3次后,用2%多聚甲醛室温下重悬固定细胞20分钟后,用洗涤液(PBS+10v/v%FCS)洗涤去除固定液2. Harvest the cells; after washing 2-3 times with low-temperature PBS, resuspend and fix the cells with 2% paraformaldehyde at room temperature for 20 minutes, then wash with washing solution (PBS+10v/v% FCS) to remove the fixing solution
3、用破膜剂(PBS+0.1v/v%Triton)室温下处理细胞20分钟后,用洗涤液洗涤去除破膜剂。3. After treating the cells with a membrane-breaking agent (PBS+0.1v/v% Triton) at room temperature for 20 minutes, wash with a washing solution to remove the membrane-breaking agent.
4、用Edu标记溶剂混合物(100mM Tris中混合1mM CuSO4,0.1μM azide-alexaFluro 488和100mM抗坏血酸溶液)重悬细胞,室温下处理细胞20分钟后,用洗涤液洗涤细胞去除多余试剂。4. Resuspend the cells with Edu labeling solvent mixture (100mM Tris mixed with 1mM CuSO4, 0.1μM azide-alexaFluro 488 and 100mM ascorbic acid solution), treat the cells at room temperature for 20 minutes, and wash the cells with washing solution to remove excess reagents.
5、加入10μg/ml p-H3-Alexa Fluro647重悬细胞,4℃染色细胞30分钟后,用洗涤液充分洗涤去除多余抗体。5. Add 10 μg/ml p-H3-Alexa Fluro647 to resuspend the cells. After staining the cells at 4°C for 30 minutes, wash them thoroughly with washing solution to remove excess antibodies.
6、用PBS将细胞调整到0.1×106/ml~1×106/ml浓度,取100μl细胞悬液甩片到载玻片上。6. Adjust the cells to a concentration of 0.1×10 6 /ml to 1×10 6 /ml with PBS, take 100 μl of the cell suspension and spin it onto a glass slide.
7、用1μg/ml DAPI室温下染色10分钟后,用PBS充分洗涤4-5次。7. After staining with 1 μg/ml DAPI at room temperature for 10 minutes, wash thoroughly with PBS 4-5 times.
8、滴加上样缓冲液(90v/v%甘油+10v/v%pH9的PBS),加上盖玻片,并封片。8. Add sample buffer solution (90v/v% glycerol + 10v/v% pH9 PBS) dropwise, add a cover slip, and mount the slide.
9、将细胞样本在荧光显微镜下观察。9. Observe the cell sample under a fluorescence microscope.
上述实验方法是以悬浮细胞为例。如果实验对象是贴壁细胞,可以先将细胞培养于载玻片上,然后转移到培养皿中。基本过程类似,可以省掉细胞甩片的过程。The above experimental method is based on suspension cells as an example. If the subject of the experiment is adherent cells, the cells can be cultured on a glass slide and then transferred to a petri dish. The basic process is similar, and the process of cell flake removal can be omitted.
利用细胞周期荧光检测试剂盒对K562细胞增殖周期的检测结果见图1。其中,左上图显示DAPI染色所有细胞的DNA。染色后的荧光强度在不同细胞周期细胞间有不同;右上图显示Edu染色新合成DNA,这类阳性染色细胞代表S期细胞;左下图显示磷酸化组蛋白H3抗体染色细胞,这类细胞都是M期细胞,其染色体具有特征性。The detection results of the proliferation cycle of K562 cells using the cell cycle fluorescence detection kit are shown in Figure 1. Among them, the upper left panel shows that DAPI stains the DNA of all cells. The fluorescence intensity after staining varies among different cell cycle cells; the upper right panel shows newly synthesized DNA stained by Edu, and these positively stained cells represent S-phase cells; the lower left panel shows phosphorylated histone H3 antibody-stained cells, these cells are Cells in M phase, whose chromosomes are characteristic.
染色后的细胞用流式细胞术检测验证结果见图2。其中,左上图为散点图,显示所有细胞的大小和胞内状况;右上图显示单个细胞分布图;左下图DAPI和Edu-AF488染色后将细胞区分为G1,S和G2/M三个增殖周期;右下图显示p-H3-Alexa Fluro647可以将G2/M期细胞区分开来,抗体阳性细胞为M期细胞。证明了图1中的染色效率敏感特异性。The stained cells were verified by flow cytometry and the results are shown in Figure 2. Among them, the upper left image is a scatter plot, showing the size and intracellular status of all cells; the upper right image shows the distribution of individual cells; the lower left image is divided into three types of proliferation: G1, S and G2/M after staining with DAPI and Edu-AF488 Cycle; the lower right panel shows that p-H3-Alexa Fluro647 can distinguish G2/M phase cells, and the antibody positive cells are M phase cells. The staining efficiency-sensitive specificity in Figure 1 was demonstrated.
实施例2固定剂破膜剂筛选优化实验Embodiment 2 Screening optimization experiment of fixative membrane breaking agent
实验过程与实施例1基本相同,仅改变步骤2和3中的固定剂及破膜剂组合:A:2%多聚甲醛及saponin(皂素);B:2%多聚甲醛及含0.1v/v%Triton的PBS;C:低温乙醇;D:商用试剂盒(ThermoFisher Scientific,货号A10266)。实验结果见图3。A-D结果分别来自上述四种组合。图中P3显示G2/M期细胞。其中B组合得到的结果与现有的商用两试剂组合类似,为优选出的应用试剂。The experimental process is basically the same as in Example 1, only the combination of fixative and membrane breaker in steps 2 and 3 is changed: A: 2% paraformaldehyde and saponin (saponin); B: 2% paraformaldehyde and 0.1v /v% Triton in PBS; C: low temperature ethanol; D: commercial kit (ThermoFisher Scientific, Cat. No. A10266). The experimental results are shown in Figure 3. A-D results are from the above four combinations respectively. P3 in the figure shows cells in G2/M phase. Among them, the result obtained by combination B is similar to that of the existing commercial two-reagent combination, and is the preferred applied reagent.
实施例3p-H3-Alexa Fluro647抗体优选实验Example 3 p-H3-Alexa Fluro647 antibody optimization experiment
实验过程与实施例1基本相同,仅改变步骤5中的抗体,选用不同来源的p-H3-Alexa Fluro647抗体以比较选择最佳染色的抗体A:pS28-H3-Histone-APC(Miltenyi,130-126-509);B:pS28-H3-Histone-Alexa Fluro647(BD,558609);C:pS10-H3-Histone-AlexaFluro647(Abcam,ab5176);D:pS28-H3-Histone-Alexa Fluro647(Abcam,ab237418)。验证结果用流式细胞术直方图见图4。A-D结果分别来自上述四种抗体染色结果。图中P4显示抗体染色的M期细胞。其中D组合得到的结果明显优于其他三组,为优选出的应用试剂。The experimental process is basically the same as in Example 1, only the antibody in step 5 is changed, and p-H3-Alexa Fluro647 antibody from different sources is selected to compare and select the best stained antibody A: pS28-H3-Histone-APC (Miltenyi, 130- 126-509); B: pS28-H3-Histone-Alexa Fluro647 (BD, 558609); C: pS10-H3-Histone-AlexaFluro647 (Abcam, ab5176); D: pS28-H3-Histone-Alexa Fluro647 (Abcam, ab237418 ). The verification results are shown in Figure 4 with flow cytometry histogram. A-D results are from the above four antibody staining results respectively. Panel P4 shows antibody-stained cells in M phase. Among them, the result obtained by combination D is obviously better than that of the other three groups, and it is the best applied reagent.
实施例4不同来源Edu优选实验Example 4 Different sources of Edu optimization experiment
实验过程与实施例1基本相同,仅改变步骤1中的Edu,选用不同来源的Edu以比较选择最佳染色结果。A:Invitrogen,A10266;B:Aladdin,E131265;C:RHAWN,R014330;D:MCE,HY118411。验证结果用流式细胞散点图见图5。A-D结果分别来自上述四种试剂。尽管四个实验组中的Edu都能很好地嵌入S期细胞中,且其阳性细胞比例基本相同。考虑到产品纯度,价格及供货地点等因素,最终优选Aladdin生产的Edu。The experimental process is basically the same as in Example 1, except that the Edu in step 1 is changed, and Edu from different sources is selected for comparison to select the best dyeing result. A: Invitrogen, A10266; B: Aladdin, E131265; C: RHAWN, R014330; D: MCE, HY118411. The verification results are shown in Figure 5 with the flow cytometry scatter plot. A-D results are from the above four reagents respectively. Although Edu in the four experimental groups can be well embedded in S phase cells, and the proportion of positive cells is basically the same. Considering factors such as product purity, price and supply location, Edu produced by Aladdin is finally preferred.
虽然,上文中已经用一般性说明及具体实施方案对本发明作了详尽的描述,但在本发明基础上,可以对之做一些修改或改进,这对本领域技术人员而言是显而易见的。因此,在不偏离本发明精神的基础上所做的这些修改或改进,均属于本发明要求保护的范围。Although the present invention has been described in detail with general descriptions and specific embodiments above, it is obvious to those skilled in the art that some modifications or improvements can be made on the basis of the present invention. Therefore, the modifications or improvements made on the basis of not departing from the spirit of the present invention all belong to the protection scope of the present invention.
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210167020.2A CN116678810A (en) | 2022-02-23 | 2022-02-23 | Cell Proliferation Immunofluorescence Detection Kit and Its Application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210167020.2A CN116678810A (en) | 2022-02-23 | 2022-02-23 | Cell Proliferation Immunofluorescence Detection Kit and Its Application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116678810A true CN116678810A (en) | 2023-09-01 |
Family
ID=87779658
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210167020.2A Pending CN116678810A (en) | 2022-02-23 | 2022-02-23 | Cell Proliferation Immunofluorescence Detection Kit and Its Application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116678810A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180282690A1 (en) * | 2015-10-05 | 2018-10-04 | Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. | Method and culture medium for ex vivo culturing of epidermis-derived stem cells |
| CN108866146A (en) * | 2018-07-04 | 2018-11-23 | 中国医学科学院放射医学研究所 | A kind of cell cycle detection kit |
| US20190209598A1 (en) * | 2015-12-29 | 2019-07-11 | The Board Of Trustees Of The Leland Stanford Junior University | Use of a dhodh inhibitor in combination with an inhibitor of pyrimidine salvage |
| CN110603254A (en) * | 2016-11-30 | 2019-12-20 | 班塔姆制药有限责任公司 | Substituted pyrazole compounds and methods of using the same for treating hyperproliferative diseases |
-
2022
- 2022-02-23 CN CN202210167020.2A patent/CN116678810A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20180282690A1 (en) * | 2015-10-05 | 2018-10-04 | Max-Planck-Gesellschaft zur Förderung der Wissenchaften e.V. | Method and culture medium for ex vivo culturing of epidermis-derived stem cells |
| US20190209598A1 (en) * | 2015-12-29 | 2019-07-11 | The Board Of Trustees Of The Leland Stanford Junior University | Use of a dhodh inhibitor in combination with an inhibitor of pyrimidine salvage |
| CN110603254A (en) * | 2016-11-30 | 2019-12-20 | 班塔姆制药有限责任公司 | Substituted pyrazole compounds and methods of using the same for treating hyperproliferative diseases |
| CN108866146A (en) * | 2018-07-04 | 2018-11-23 | 中国医学科学院放射医学研究所 | A kind of cell cycle detection kit |
Non-Patent Citations (2)
| Title |
|---|
| 苏燎原,刘芬菊: "医学放射生物学基础", 31 January 2013, 原子能出版社, pages: 86 * |
| 郭维华,李中瀚: "口腔细胞实验操作技术", 30 June 2021, 四川大学出版社, pages: 83 - 85 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Huang et al. | Gelatin nanoparticle-coated silicon beads for density-selective capture and release of heterogeneous circulating tumor cells with high purity | |
| Lee et al. | Development of the “Three-step MACS”: a novel strategy for isolating rare cell populations in the absence of known cell surface markers from complex animal tissue | |
| JP2021175415A (en) | Methods of preparing primary cell sample | |
| CN105067808A (en) | High-purity circulation tumor cell enriching method and kit | |
| CN105954246A (en) | Method and kit for detecting free rare tumor cells in human biofluid sample | |
| CN110608991B (en) | Cell cycle detection kit and detection method based on mass spectrometry | |
| JP2018531021A6 (en) | Methods for preparing primary cell samples | |
| CN102279264A (en) | Preparation process for chip with 48 malignant tumor marker antibodies | |
| CN111189761A (en) | Cell signal channel detection kit based on mass spectrometry flow technology and detection method | |
| CN110095599A (en) | The Microimmunofluorescence test method of cell-free loss | |
| CN109799350B (en) | Method and application of protein thermostability measurement combined with bidirectional stable isotope labeling proteomics for drug target screening | |
| CN109439624B (en) | A method for identifying or enriching nucleated red blood cells | |
| CN110361442A (en) | A kind of excretion body and the preparation method and application thereof for mass spectrum flow cytomery | |
| Kubíková et al. | Proteomic profiling of human embryonic stem cell-derived microvesicles reveals a risk of transfer of proteins of bovine and mouse origin | |
| CN118688452B (en) | Exosome detection biosensor and detection method based on engineering bacteria | |
| Liew et al. | JAK2 as a surface marker for enrichment of human pluripotent stem cells-derived ventricular cardiomyocytes | |
| WO2018107930A1 (en) | Peripheral-blood circulating tumor cell detection system and application thereof | |
| CN116678810A (en) | Cell Proliferation Immunofluorescence Detection Kit and Its Application | |
| CN113049558A (en) | Method for marking eukaryotic cells by using coptisine as fluorescent probe and application | |
| CN108866064A (en) | A kind of aptamer of targeted metastatic human breast cancer cell and its application | |
| CA2438406A1 (en) | Materials and methods for the induction of premature chromosome condensation | |
| CN111596053B (en) | Use of TPN molecule in preparation of circulating tumor cell detection reagent, detection reagent and kit | |
| CN114487394A (en) | Cell cycle detection kit and application thereof | |
| US7943304B2 (en) | Method and apparatus for chromosome profiling | |
| CN113960313B (en) | Exosome ALK fusion protein magnetic immunochemiluminescence detection kit |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |